Penumbra, Inc. (NYSE:PEN) Shares Sold by Congress Wealth Management LLC DE

Congress Wealth Management LLC DE lowered its holdings in Penumbra, Inc. (NYSE:PEN) by 0.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 79,868 shares of the company’s stock after selling 590 shares during the period. Congress Wealth Management LLC DE’s holdings in Penumbra were worth $18,967,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. FMR LLC increased its position in shares of Penumbra by 2.1% in the third quarter. FMR LLC now owns 5,896,396 shares of the company’s stock worth $1,145,729,000 after acquiring an additional 121,465 shares in the last quarter. State Street Corp grew its position in Penumbra by 0.3% during the third quarter. State Street Corp now owns 1,236,671 shares of the company’s stock valued at $240,298,000 after purchasing an additional 3,863 shares in the last quarter. RTW Investments LP grew its position in Penumbra by 7.2% during the third quarter. RTW Investments LP now owns 795,750 shares of the company’s stock valued at $154,622,000 after purchasing an additional 53,645 shares in the last quarter. Baillie Gifford & Co. grew its position in Penumbra by 23.4% during the fourth quarter. Baillie Gifford & Co. now owns 730,233 shares of the company’s stock valued at $173,416,000 after purchasing an additional 138,387 shares in the last quarter. Finally, Janus Henderson Group PLC grew its position in Penumbra by 128.1% during the third quarter. Janus Henderson Group PLC now owns 668,873 shares of the company’s stock valued at $129,967,000 after purchasing an additional 375,684 shares in the last quarter. Institutional investors and hedge funds own 88.88% of the company’s stock.

Penumbra Trading Down 0.1 %

PEN opened at $280.93 on Monday. Penumbra, Inc. has a twelve month low of $148.00 and a twelve month high of $310.00. The company has a 50-day simple moving average of $272.70 and a 200 day simple moving average of $240.56. The company has a quick ratio of 3.25, a current ratio of 6.01 and a debt-to-equity ratio of 0.02. The stock has a market capitalization of $10.82 billion, a price-to-earnings ratio of 826.25, a P/E/G ratio of 2.83 and a beta of 0.51.

Penumbra (NYSE:PEN) last posted its quarterly earnings data on Tuesday, February 18th. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.88 by $0.09. Penumbra had a net margin of 1.17% and a return on equity of 9.74%. The business had revenue of $315.52 million during the quarter, compared to analysts’ expectations of $311.63 million. Analysts predict that Penumbra, Inc. will post 3.67 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the stock. Canaccord Genuity Group boosted their price objective on shares of Penumbra from $323.00 to $340.00 and gave the company a “buy” rating in a research report on Wednesday, February 19th. BTIG Research boosted their price objective on shares of Penumbra from $232.00 to $270.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. Citigroup boosted their target price on shares of Penumbra from $220.00 to $245.00 and gave the stock a “neutral” rating in a research report on Wednesday, December 11th. Piper Sandler reaffirmed an “overweight” rating and set a $330.00 target price (up previously from $250.00) on shares of Penumbra in a research report on Wednesday, February 19th. Finally, Morgan Stanley boosted their price target on shares of Penumbra from $240.00 to $260.00 and gave the company an “equal weight” rating in a report on Wednesday, February 19th. Four equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $294.47.

Insider Buying and Selling

In other Penumbra news, CAO Lambert Shiu sold 501 shares of the business’s stock in a transaction dated Tuesday, March 4th. The stock was sold at an average price of $282.88, for a total transaction of $141,722.88. Following the completion of the transaction, the chief accounting officer now owns 32,969 shares of the company’s stock, valued at approximately $9,326,270.72. The trade was a 1.50 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Adam Elsesser sold 61,600 shares of the business’s stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of $283.59, for a total value of $17,469,144.00. Following the transaction, the chief executive officer now directly owns 16,376 shares of the company’s stock, valued at approximately $4,644,069.84. The trade was a 79.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 81,518 shares of company stock valued at $22,994,979 over the last quarter. 5.00% of the stock is owned by company insiders.

Penumbra Company Profile

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.